Skip to content
August 10, 2022

Equity.Guru

Investment information for the new generation

patents

Most science fiction writers looking ahead to the 21st century didn’t envision a world where a lot of our daily lives feels like suffering the tedious death of a…
Filament Health (FH.NEO) filed their 20th patent application for their research phase programs, including three international Patent Cooperation Treaty (PCT) applications, earlier this week, according to a press release….
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been…
For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which…
Cybin (CYBN.E) filed a new provisional patent application for its ongoing drug candidate programs today, according to a press release. The application includes compositions which the company anticipates will…
Core One Labs (COOL.C) inked a letter of intent to pick up pharmaceuticals company, Akome Biotech today, according to a press release. Akome develops psychedelic-based drugs to treat rare…
News this week that Canntab Therapeutics (PILL.C) received an Australian patent for their hard-pressed cannabis pill tech, to match those received earlier in North America, didn’t launch the stock…
Victory Square Technologies (VST.C) signed a letter of intent to sell some of their intellectual property to Cloud Nine Education Group (CNI.C) today, according to a press release. The…
Nextleaf Solutions (OILS.C) received a patent for the prodrug producing, acetylation of cannabinoids today from the Canadian Intellectual Property Office, according to a press release. Specifically, the patent is…